NASDAQ:SMMT (Summit Therapeutics plc)

About SMMT

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
  • Summit Therapeutics plc (NASDAQ: SMMT) Latest News

    No posts found.